EUVIMEDEUVIMED entdecken
Crossref

Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma

Nao Kitasaki, Yoichi Hamai, Ryosuke Hirohata, Manato Ohsawa, Yuta Ibuki, Tomoaki Kurokawa, Manabu Emi, Morihito Okada

Anticancer Research · 2026

DOI: 10.21873/anticanres.18058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Nao Kitasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Esophagectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyEsophageal Squamous Cell CarcinomaEsophageal NeoplasmsEsophagectomyAntineoplastic Combined Chemotherapy ProtocolsHumansPrognosisFemaleMaleAgedFluorouracilMiddle AgedCisplatinDocetaxelTreatment Outcome

Stichwörter der Autor:innen

Chemotherapyesophagusneoadjuvant therapyresponsesurgery

Substanzen

FluorouracilCisplatinDocetaxel

Autor:innen und Institutionen

  • Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan yyhamai@hiroshima-u.ac.jp.

Zitieren

APA

Kitasaki, N., Hamai, Y., Hirohata, R., Ohsawa, M., Ibuki, Y., Kurokawa, T., Emi, M., & Okada, M. (2026). Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.18058

Vancouver

Kitasaki N, Hamai Y, Hirohata R, Ohsawa M, Ibuki Y, Kurokawa T, et al. Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma. Anticancer Research. 2026. doi:10.21873/anticanres.18058

BibTeX
@article{Kitasaki2026,
  author = {Kitasaki, Nao and Hamai, Yoichi and Hirohata, Ryosuke and Ohsawa, Manato and Ibuki, Yuta and Kurokawa, Tomoaki and Emi, Manabu and Okada, Morihito},
  title = {Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18058}
}
Kostenlos starten →